BerandaAMRN • NASDAQ
add
Amarin Corporation PLC
$13,96
Setelah Jam Perdagangan Normal:(0,90%)-0,12
$13,83
Tutup: 31 Des, 19.24.07 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$13,51
Rentang hari
$13,51 - $14,13
Rentang tahun
$7,08 - $20,90
Kapitalisasi pasar
290,16Â jt USD
Volume Rata-Rata
87,50Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 49,67Â jt | 17,43% |
Biaya operasional | 23,90Â jt | -42,32% |
Penghasilan bersih | -7,74Â jt | 69,21% |
Margin laba bersih | -15,58 | 73,78% |
Penghasilan per saham | 0,19 | 119,00% |
EBITDA | -830,00Â rb | 96,60% |
Tarif pajak efektif | 4,65% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 286,59Â jt | -6,26% |
Total aset | 659,81Â jt | -12,10% |
Total liabilitas | 200,92Â jt | -8,36% |
Total ekuitas | 458,89 jt | — |
Saham yang beredar | 20,79 jt | — |
Harga terhadap nilai buku | 0,61 | — |
Tingkat pengembalian aset | -0,64% | — |
Tingkat pengembalian modal | -0,90% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -7,74Â jt | 69,21% |
Kas dari operasi | -12,70Â jt | -438,01% |
Kas dari investasi | -12,13Â jt | 78,55% |
Kas dari pembiayaan | -248,00Â rb | -264,71% |
Perubahan kas bersih | -25,07Â jt | 57,49% |
Arus kas bebas | -35,27Â jt | -370,37% |
Tentang
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Didirikan
1 Mar 1989
Kantor pusat
Situs
Karyawan
275
